Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Drugs (Abingdon Engl). 2010 Oct;17(5):455–469. doi: 10.3109/09687630902729594

Table 5.

Stated Reason for Quitting GHB among 91 Respondents Reporting Cessation*

Reason for Quitting GHB U.S. (n=46) n (%) Non-U.S. (n=34) n (%) p value
0.15
Any Health and Safety Concerns 21 (46%) 23 (68%)
 Health risks 6 (13%) 12 (35%)
 Getting addicted 12 (26%) 7 (21%)
 Didn’t like the high 3 (7%) 4 (12%)
Any Legal or Other Non-Health Risks 25 (54%) 11 (32%)
 Difficult to get 17 (37%) 9 (26%)
 Legal risks 5 (11%) 1 (3%)
 Too expensive 3 (7%) 1 (3%)
*

7 U.S. and 4 non-U.S. respondents declined to state a reason for GHB cessation

Comparing the narrowly defined response of reasons of ‘health risks’ (n=18) with that of ‘legal risks’ (n=6) by U.S. verses non-U.S. status yields a p value=0.06 (Fisher’s exact test, two-tailed) or a p value=0.048 (Fisher’s exact test, one-tailed), based on an a priori expectation of a more frequently invoked legal rationale in the U.S. group.